Accueil   Diary - News   All news Alizé Pharma to present results

Alizé Pharma to present results

ALIZE  NEWSLETTERAlizé Pharma announced that the results from its Phase II trial for AZP-531, its unacylated ghrelin analog, conducter in patients with Prader-Willi syndrome, will be presented at two upcoming scientific conference.


Read the press release